S064 How Would You Reconstruct It
DESCRIPTION
This is essentially a Masters of Reconstruction panel. Each of the speakers presents two or three interesting cases that have multiple options for closure. The panel then discusses how they would approach the defect. The speaker then reveals how they closed the wound and why it worked or did not work and what they learned from the case.
LEARNING OBJECTIVES
Recognize there are a variety of closures for any given defect
Describe the reasoning behind why one closure was chosen over another
Discuss what goes into the decision making of outstanding surgical reconstruction
SCHEDULE
1:00 PM
Introduction
Thomas E. Rohrer, MD, FAAD, Anna A. Bar, MD, FAAD
1:05 PM
Educational Cases from Los Angeles
Andrew J. Kaufman, MD, FAAD
1:20 PM
Educational Cases from Cleveland
Jeremy S. Bordeaux, MD, MPH, FAAD
1:40 PM
Educational Cases from Boston
Emily S Ruiz, MD, FAAD
2:00 PM
Educational Cases from Pittsburgh
David G. Brodland, MD, FAAD
2:20 PM
Educational Cases from Dallas
Stanislav Nickolaevich Tolkachjov, MD, FAAD
2:40 PM
Educational Cases from Portland
Justin J. Leitenberger, MD, FAAD
3:00 PM
Educational Cases from Springfield
Michael H. Swann, MD, FAAD
3:20 PM
Educational Cases from St. Louis
Ramona Behshad, MD, FAAD
3:40 PM
Educational Cases from Vancouver
Iren Kossintseva, MD, FAAD
3:55 PM
Closing Remarks
Thomas E. Rohrer, MD, FAAD, Anna A. Bar, MD, FAAD
DIRECTOR
Thomas E. Rohrer, MD, FAAD
SPEAKERS
Anna A. Bar, MD, FAAD
Ramona Behshad, MD, FAAD
Jeremy S. Bordeaux, MD, MPH, FAAD
David G. Brodland, MD, FAAD
Andrew J. Kaufman, MD, FAAD
Iren Kossintseva, MD, FAAD
Justin J. Leitenberger, MD, FAAD
Emily S Ruiz, MD, FAAD
Michael H. Swann, MD, FAAD
Stanislav Nickolaevich Tolkachjov, MD, FAAD
DISCLOSURES
Anna A. Bar, MD, FAAD
Castle Biosciences – Investigator(Other Financial Benefit); Regeneron – Consultant(Honoraria);
Ramona Behshad, MD, FAAD
Castle Biosciences, Inc – Investigator(Grants/Research Funding);
Jeremy S. Bordeaux, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
David G. Brodland, MD, FAAD
No financial relationships exist with ineligible companies.
Andrew J. Kaufman, MD, FAAD
No financial relationships exist with ineligible companies.
Iren Kossintseva, MD, FAAD
No financial relationships exist with ineligible companies.
Justin J. Leitenberger, MD, FAAD
No financial relationships exist with ineligible companies.
Thomas E. Rohrer, MD, FAAD
Acclaro Medical – Advisory Board(Fees); Candela Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Lumenis – Investigator(Grants/Research Funding); UpToDate – Other(Honoraria);
Emily S Ruiz, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Checkpoint Therapeutics – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Merck – Investigator(Grants/Research Funding); Regeneron – Advisory Board(Fees), Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees), Consultant (1099 relationship)(Fees);
Michael H. Swann, MD, FAAD
No financial relationships exist with ineligible companies.
Stanislav Nickolaevich Tolkachjov, MD, FAAD
Boehringer Ingelheim – Speaker(Honoraria); Castle Biosciences – Speaker(Honoraria); Kerecis Limited – Speaker(Grants/Research Funding); Leo Pharma – Speaker(Honoraria);